ORTI B Stock Overview
Ortivus AB (publ) develops and commercializes medical technology solutions for healthcare industry in Sweden and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Ortivus AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr2.68 |
| 52 Week High | kr4.99 |
| 52 Week Low | kr2.07 |
| Beta | 0.70 |
| 1 Month Change | -4.29% |
| 3 Month Change | -17.28% |
| 1 Year Change | -42.74% |
| 3 Year Change | -44.69% |
| 5 Year Change | 41.42% |
| Change since IPO | -97.02% |
Recent News & Updates
Shareholder Returns
| ORTI B | SE Healthcare Services | SE Market | |
|---|---|---|---|
| 7D | -5.6% | -1.3% | -1.6% |
| 1Y | -42.7% | 23.2% | 7.8% |
Return vs Industry: ORTI B underperformed the Swedish Healthcare Services industry which returned 23.2% over the past year.
Return vs Market: ORTI B underperformed the Swedish Market which returned 7.8% over the past year.
Price Volatility
| ORTI B volatility | |
|---|---|
| ORTI B Average Weekly Movement | 9.5% |
| Healthcare Services Industry Average Movement | 6.2% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in SE Market | 12.8% |
| 10% least volatile stocks in SE Market | 3.4% |
Stable Share Price: ORTI B's share price has been volatile over the past 3 months.
Volatility Over Time: ORTI B's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | 41 | Gustaf Nordenhok | www.ortivus.com |
Ortivus AB (publ) develops and commercializes medical technology solutions for healthcare industry in Sweden and internationally. The company offers MobiMed Monitor that monitors and measures the patient’s vital parameters, such as ECG, blood pressure, and blood oxygenation; MobiMed ePR, an electronic patient record system for documentation of treatment and events; MobiMed Life, which is designed for advanced monitoring and resuscitation; and MobiMed Cloud that supports multiplatform data sharing on Windows, Webb, IOS, and Android. It also provides support, implementation, training, and consulting services.
Ortivus AB (publ) Fundamentals Summary
| ORTI B fundamental statistics | |
|---|---|
| Market cap | kr123.60m |
| Earnings (TTM) | -kr18.24m |
| Revenue (TTM) | kr84.08m |
1.4x
P/S Ratio-6.5x
P/E RatioIs ORTI B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ORTI B income statement (TTM) | |
|---|---|
| Revenue | kr84.08m |
| Cost of Revenue | kr53.24m |
| Gross Profit | kr30.84m |
| Other Expenses | kr49.09m |
| Earnings | -kr18.24m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.41 |
| Gross Margin | 36.68% |
| Net Profit Margin | -21.70% |
| Debt/Equity Ratio | 0% |
How did ORTI B perform over the long term?
See historical performance and comparison